WHWK
NA
$3.41
-$0.02(-0.58%)
51
Overall
60
Value
50
Tech
44
Quality
Market Cap
$100.38M
Volume
153.88K
52W Range
$1.39 - $4.48
Target Price
$5.67
Company Overview
| Mkt Cap | $100.38M | Price | $3.41 |
| Volume | 153.88K | Change | -0.58% |
| P/E Ratio | -1.6 | Open | $3.54 |
| Revenue | $26.0M | Prev Close | $3.43 |
| Net Income | $-63.7M | 52W Range | $1.39 - $4.48 |
| Div Yield | N/A | Target | $5.67 |
| Overall | 51 | Value | 60 |
| Quality | 44 | Technical | 50 |
No chart data available
About NA
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Latest News
JonesTrading Sticks to Their Buy Rating for Whitehawk Therapeutics (WHWK)
TipRanks Auto-Generated Intelligence Newsdesk•2 days ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rapid Micro Biosystems (RPID), Lexicon Pharmaceuticals (LXRX) and Whitehawk Therapeutics (WHWK)
Christine Brown•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WHWK | $3.41 | -0.6% | 153.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |